The GenAI Hype Cycle Is Hiding Real Commercial Risk
Enterprise buyers are racing to deploy GenAI tools, but many are locking themselves into high-risk, inflexible OpenAI contracts without fully grasping the long-term cost and compliance exposure. With opaque pricing models, audit-free enforcement, and silent consumption traps, a new wave of OpenAI licensing risk is emerging—one that can spiral quickly without firm contractual safeguards in place.
This playbook gives you the inside view of what’s actually being signed in enterprise contracts, where large buyers are getting caught, and how to structure your negotiation strategy to stay in control.
OpenAI won’t make it easy. This is how you push back.